CAS 192387-38-5

NEUROPEPTIDE AF (HUMAN)

Description:

Neuropeptide AF (Human), with the CAS number 192387-38-5, is a neuropeptide that plays a significant role in the central nervous system, particularly in modulating pain, stress responses, and various neuroendocrine functions. It is derived from the precursor protein pro-neuropeptide AF and is known for its involvement in the regulation of anxiety and depression-related behaviors. This peptide exhibits a high affinity for specific neuropeptide receptors, influencing neurotransmission and neuroplasticity. Structurally, neuropeptides like AF are characterized by their relatively small size and specific amino acid sequences, which determine their biological activity. Neuropeptide AF is also implicated in the modulation of energy homeostasis and may have potential therapeutic applications in treating mood disorders and metabolic conditions. Its stability and activity can be influenced by various factors, including pH and temperature, making it an interesting subject for research in neurobiology and pharmacology. Overall, neuropeptide AF represents a crucial component of the neuropeptide signaling system in humans.

Formula: C₉₀H₁₃₂N₂₆O₂₅

Synonyms:

• H-Ala-Gly-Glu-Gly-Leu-Asn-Ser-Gln-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-Nh2
• NEUROPEPTIDE AF (HUMAN) USP/EP/BP
• A-18-F-aMide (huMan), NPAF (huMan)
• NEUROPEPTIDE AF (HUMAN)
• Neuropeptide AF (93-110), Human
• Neuropeptide AF (huMan)

Neuropeptide AF (human)

CAS: 192387-38-5

Neuropeptide AF (93-110), Human is an endogenous antiopioid peptide.

Formula: C₉₀H₁₃₂N₂₆O₂₅

Purity: 98%

Color and Shape: Solid

Molecular weight: 1978.17

Ref: TM-TP1082

Neuropeptide AF (human) trifluoroacetate salt

CAS: 192387-38-5

Neuropeptide AF is a peptide that is synthesized in the brain and has been shown to have a wide range of biological activities. It has been shown to block growth factor-β1, activate the ryanodine receptor, and cause neuronal death. Neuropeptide AF also activates the polymerase chain reaction (PCR) and can be used as a potential biomarker for Alzheimer's disease. Neuropeptide AF has been shown to decrease body mass index and improve long-term efficacy in patients with chronic heart disease. There is also evidence that Neuropeptide AF binds calcium ions, which may play a role in structural heart disease or cardiac function.

Formula: C₉₀H₁₃₂N₂₆O₂₅

Purity: Min. 95%

Molecular weight: 1,978.17 g/mol

Ref: 3D-FN109417